Search research articles
Contact Us
Filters
Showing results (71-80 of 204) with videos related to
Page
of 21
Sort By:
Expert Review of Anti-Infective Therapy
|
May 31, 2019
Quantitative assessment of the activity of antituberculosis drugs and regimens
Maxwell T Chirehwa, Gustavo E Velásquez, Tawanda Gumbo, et al.
The Lancet. Respiratory Medicine
|
March 30, 2018
Pan-tuberculosis regimens: an argument against
Keertan Dheda, Tawanda Gumbo, Christoph Lange, et al.
Antimicrobial Agents and Chemotherapy
|
November 25, 2010
In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis
Prakash M Jeena, William R Bishai, Jotam G Pasipanodya, et al.
Antimicrobial Agents and Chemotherapy
|
May 20, 2009
Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs
Tawanda Gumbo, Chandima S W Siyambalapitiyage Dona, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
August 6, 2014
Redefining multidrug-resistant tuberculosis based on clinical response to combination therapy
Tawanda Gumbo, Jotam G Pasipanodya, Peter Wash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 31, 2015
Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
Tawanda Gumbo, Jotam G Pasipanodya, Eric Nuermberger, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease
Jotam G Pasipanodya, Deborah Ogbonna, Devyani Deshpande, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 31, 2015
Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments
Jotam G Pasipanodya, Eric Nuermberger, Klaus Romero, et al.
The Journal of Infectious Diseases
|
May 27, 2015
Nonclinical models for antituberculosis drug development: a landscape analysis
Tawanda Gumbo, Anne J Lenaerts, Debra Hanna, et al.
The Journal of Infectious Diseases
|
October 25, 2011
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability
Shashikant Srivastava, Jotam G Pasipanodya, Claudia Meek, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 204) with videos related to
Sort By:
Page
of 21
Expert Review of Anti-Infective Therapy
|
May 31, 2019
Quantitative assessment of the activity of antituberculosis drugs and regimens
Maxwell T Chirehwa, Gustavo E Velásquez, Tawanda Gumbo, et al.
The Lancet. Respiratory Medicine
|
March 30, 2018
Pan-tuberculosis regimens: an argument against
Keertan Dheda, Tawanda Gumbo, Christoph Lange, et al.
Antimicrobial Agents and Chemotherapy
|
November 25, 2010
In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis
Prakash M Jeena, William R Bishai, Jotam G Pasipanodya, et al.
Antimicrobial Agents and Chemotherapy
|
May 20, 2009
Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs
Tawanda Gumbo, Chandima S W Siyambalapitiyage Dona, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
August 6, 2014
Redefining multidrug-resistant tuberculosis based on clinical response to combination therapy
Tawanda Gumbo, Jotam G Pasipanodya, Peter Wash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 31, 2015
Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
Tawanda Gumbo, Jotam G Pasipanodya, Eric Nuermberger, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease
Jotam G Pasipanodya, Deborah Ogbonna, Devyani Deshpande, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 31, 2015
Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments
Jotam G Pasipanodya, Eric Nuermberger, Klaus Romero, et al.
The Journal of Infectious Diseases
|
May 27, 2015
Nonclinical models for antituberculosis drug development: a landscape analysis
Tawanda Gumbo, Anne J Lenaerts, Debra Hanna, et al.
The Journal of Infectious Diseases
|
October 25, 2011
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability
Shashikant Srivastava, Jotam G Pasipanodya, Claudia Meek, et al.
Page
of 21